It is a chemicals private limited company based in Hyderabad, Telangana, India, established in 2020.
2020 | Hyderabad, Telangana, India | ActiveStrigine Pharmaceuticals Private Limited, a active private limited company, was established on 23 June 2020 in Hyderabad, Telangana, India. Engaging in manufacturing within the chemicals sector, it holds CIN: U24230TG2020PTC141047. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹1.50 M and a paid-up capital of ₹0.50 M.
Its leadership includes Srilakshmi Nannuri Suryanarayana Rao (Director), Edara Hari Babu (Director). Past directors included Srikanthreddy Kolli, Sushma Marupudi. Its latest AGM occurred on 30 September 2023, with the balance sheet filed on 31 March 2023. It is based at Plot No: 177, 4Th Floor, Lahari Estates Opp Vijetha Super Market,Pragathi Nagar,, Kukatpally, Hyderabad, Telangana, 500090.
U24230TG2020PTC141047
141047
23 June 2020
₹1.50 M
₹0.50 M
Roc Hyderabad
Unlisted
Active
Explore comprehensive insights into Strigine Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Srilakshmi Nannuri Suryanarayana Rao | Director | 23 Jun 2020 | Current |
| Edara Hari Babu | Director | 25 May 2022 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 25 May 2022 | Past |
| Pramod Abcsdd | Director | 25 May 2022 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Strigine Pharmaceuticals Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 62.14% decrease. The company also saw a substantial improvement in profitability, with a 89.13% increase in profit. The company's net worth observed a substantial decline by a decrease of 14.51%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Strigine Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Strigine Pharmaceuticals has a workforce of 0 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Strigine Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Strigine Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Strigine Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records. was recorded as a recent event.
Strigine Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Hyderabad. was recorded as a recent event.
Progress on Edara Hari Babu was appointed as a Director was appointed as a Director on 25 May 2022 & has been associated with this company since 3 years 7 months . was documented.
The activity Srilakshmi Nannuri Suryanarayana Rao was appointed as a Director was appointed as a Director on 23 Jun 2020 & has been associated with this company since 5 years 6 months . was completed.
Strigine Pharmaceuticals Private Limited was registered on 23 Jun 2020 with Roc Hyderabad & aged 5 years 6 months as per MCA records. was recorded as a recent event.
The CIN of Strigine Pharmaceuticals Private Limited is U24230TG2020PTC141047.
Strigine Pharmaceuticals Private Limited is headquartered at Plot No: 177, 4Th Floor, Lahari Estates Opp Vijetha Super Market,Pragathi Nagar,, Kukatpally, Hyderabad, Telangana, 500090.
Strigine Pharmaceuticals Private Limited was incorporated on 23 June 2020.
The current directors of Strigine Pharmaceuticals Private Limited are
The primary industry of Strigine Pharmaceuticals Private Limited is Chemicals.
Strigine Pharmaceuticals Private Limited is unlisted.
The authorized capital of Strigine Pharmaceuticals Private Limited is ₹1.50 M, and the paid-up capital is ₹0.50 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX